Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1295427.RAcOS3g4UwvnhAIMTODRxzhRFSUgV5I8bW98oSDBREkDQ130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1295427.RAcOS3g4UwvnhAIMTODRxzhRFSUgV5I8bW98oSDBREkDQ130_assertion type Assertion NP1295427.RAcOS3g4UwvnhAIMTODRxzhRFSUgV5I8bW98oSDBREkDQ130_head.
- NP1295427.RAcOS3g4UwvnhAIMTODRxzhRFSUgV5I8bW98oSDBREkDQ130_assertion description "[We prospectively assessed the relation between early PSMD4, BIRC5, and KIAA1754 gene expression changes (before therapy and one week later) and the response rate after bortezomib-based therapy in 25 patients with newly diagnosed MM.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1295427.RAcOS3g4UwvnhAIMTODRxzhRFSUgV5I8bW98oSDBREkDQ130_provenance.
- NP1295427.RAcOS3g4UwvnhAIMTODRxzhRFSUgV5I8bW98oSDBREkDQ130_assertion evidence source_evidence_literature NP1295427.RAcOS3g4UwvnhAIMTODRxzhRFSUgV5I8bW98oSDBREkDQ130_provenance.
- NP1295427.RAcOS3g4UwvnhAIMTODRxzhRFSUgV5I8bW98oSDBREkDQ130_assertion SIO_000772 26537080 NP1295427.RAcOS3g4UwvnhAIMTODRxzhRFSUgV5I8bW98oSDBREkDQ130_provenance.
- NP1295427.RAcOS3g4UwvnhAIMTODRxzhRFSUgV5I8bW98oSDBREkDQ130_assertion wasDerivedFrom befree-2016 NP1295427.RAcOS3g4UwvnhAIMTODRxzhRFSUgV5I8bW98oSDBREkDQ130_provenance.
- NP1295427.RAcOS3g4UwvnhAIMTODRxzhRFSUgV5I8bW98oSDBREkDQ130_assertion wasGeneratedBy ECO_0000203 NP1295427.RAcOS3g4UwvnhAIMTODRxzhRFSUgV5I8bW98oSDBREkDQ130_provenance.